DOCSLIB.ORG

Genetic, Evolutionary, and Genomic Analysis Of

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Genetic, Evolutionary, and Genomic Analysis Of GENETIC, EVOLUTIONARY, AND GENOMIC ANALYSIS OF HOMOCYSTEINE AND FOLATE PATHWAY REGULATION By TOSHIMORI KITAMI Submitted in partial fulfillment of the requirements For the degree of Doctor of Philosophy Thesis Adviser: Dr. Joseph H. Nadeau Department of Genetics CASE WESTERN RESERVE UNIVERSITY January, 2006 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the dissertation of ______________________________________________________ candidate for the Ph.D. degree *. (signed)_______________________________________________ (chair of the committee) ________________________________________________ ________________________________________________ ________________________________________________ ________________________________________________ ________________________________________________ (date) _______________________ *We also certify that written approval has been obtained for any proprietary material contained therein. TABLE OF CONTENTS TABLE OF CONTENTS 1 LIST OF TABLES 3 LIST OF FIGURES 4 ACKNOWLEDGEMENTS 5 ABSTRACT 6 CHAPTER 1: INTRODUCTION AND OBJECTIVES 8 Homocysteine, Folate, and Human Disease Risks 9 Introduction 9 Box 1: Different types of clinical studies 10 Non-genetic factors that affect homocysteine level 13 Effect of folate on homocysteine level 14 Cardiovascular disease 15 Neural tube defect 18 Cancer 20 Alzheimer’s disease and dementia 24 Genetic Mutations in Homocysteine and Folate Metabolism 25 Rare mutations 25 Common mutation (Mthfr C677T mutation) 26 Mthfr C677T mutation and disease risks 27 Mouse Models and Disease Mechanisms 32 Basic Biochemistry of Homocysteine and Folate Pathways 36 Regulation of Homocysteine and Folate Pathways 39 Positive and negative feedback 39 Polyglutamation of folate 40 Tissue specific regulation 40 Folate transport 41 Transcriptional regulation 42 Global perspective on homocysteine and folate pathway regulation 43 Research Objective 45 CHAPTER 2: GENETIC AND PHENOTYPIC ANALYSIS OF MTHFR ENZYME ACTIVITY, TAIL KINKS, AND SEIZURE SUSCEPTIBILITY IN PL/J MICE 48 Abstract 49 Introduction 50 Materials and Methods 52 Results 54 Discussion 60 1 CHAPTER 3: GENE DUPLICATION, METABOLIC NETWORKING, AND GENETIC BUFFERING IN PHYSIOLOGICAL PATHWAYS OF HUMAN AND MICE 65 Abstract 66 Introduction 67 Materials and Methods 70 Results 76 Discussion 84 CHAPTER 4: GLOBAL GENE EXPRESSION AND METABOLITE PROFILING OF RESPONSES TO DIETARY FOLATE PERTURBATIONS IN TWO GENETICALLY DISTINCT INBRED MOUSE STRAINS 88 Abstract 89 Introduction 90 Materials and Methods 93 Results 100 Discussion 112 CHAPTER 5: SUMMARY AND FUTURE DIRECTIONS 117 Summary 118 Future Directions 120 APPENDIX 127 Appendix 1: Nomenclature of Homocysteine and Folate Enzymes 128 Appendix 2: Nutrient Composition of Folate Deficient and Control Diets 129 BIBLIOGRAPHY 130 2 LIST OF TABLES CHAPTER 1 1.1 Summary of cohort studies on colon cancer risk and homocysteine and folate levels 23 1.2 Summary of association studies between Mthfr C677T and colon cancer risk 29 1.3 Summary of association studies between Mhtfr C677T and neural tube defect risk 31 CHAPTER 3 3.1 Average Ka/Ks values for orthologous genes in various metabolic pathways in humans and mice 78 CHAPTER 4 4.1 Significant over-representation of Gene Ontology terms 103 4.2 Effect of ApoE knockout and dietary choline supplements on metabolite and gene expression profiles 107 3 LIST OF FIGURES CHAPTER 1 1.1 Homocysteine and folate pathways 38 CHAPTER 2 2.1 Amino acid sequence alignment of Mthfr in five model organisms 56 2.2 X-ray photograph of a kinky tail in a PL/J mouse 56 2.3 Number of tests with seizures in parental, F1, and F2 mice 59 CHAPTER 3 3.1 Schematic for defining networks based on the structure of metabolic pathways 75 3.2 Distribution of Ka/Ks values for 241 genes in various metabolic pathways 79 3.3 Scatter plot of the Ka/Ks values and the number of tissues with gene expression from mouse and human gene expression data 83 CHAPTER 4 4.1 Dietary folate perturbation protocols 94 4.2 Metabolite profiles of serum homocysteine and folate, and total cholesterol in serum and liver 101 4.3 2-dimensional plots of metabolite profiles for A/J and C57BL/6J 101 4.4 Average linkage hierarchical clustering of liver gene expression profile 103 4.5 Gene expression profile of choline kinase 111 4 ACKNOWLEDGEMENTS My thesis is a collaborative work of many people who have impacted me both on educational and personal level throughout my life. I like to thank my adviser Dr. Joseph Nadeau for teaching me to think independently, write and speak effectively, and to approach science with curiosity and passion. I also like to thank my committee members for providing variety of views on my thesis and expanding my breadth of scientific thinking. I also thank the members of the Nadeau Lab for inputs and supports throughout my graduate career. I like to thank my family for providing generous financial support throughout my life, always providing the best environment for my education and personal growth, and providing me freedom to pursue any career choice of my own. I also like to thank my Cleveland family, the Tomciks and the Linnevers, for helping me situated in this city as well as inviting me to their holiday dinners. I also like to thank my tutor from my days in Hawaii, Mrs. Murata, who taught me English as well as many valuable lessons in life. Without her work, none of my academic success would have been possible. I also like to thank her family for their kindness and generosity, delicious meals, and fun memories. I also like to thank my friends in graduate school, Josephine and Ricky (a.k.a. Mr. & Mrs. Chan), Kirsten, Sheila, Lesil, Martha, Matt, Keith, Karen and Mike, Lisa and Brian, for making my long six years enjoyable, providing me with lots of fun memories, and motivating each other to survive the pains of graduate school. 5 Genetic, Evolutionary, and Genomic Analysis of Homocysteine and Folate Pathway Regulation Abstract By TOSHIMORI KITAMI Abnormalities in homocysteine and folate metabolism are associated with increased risk for several common human diseases. Both elevated serum homocysteine and low dietary folate intake increase the risk for cardiovascular diseases, neural tube defects, cancers, and neurodegeneration. Although common mutations in these pathways have been identified, they do not fully account for the variety of disease types that are associated with increased homocysteine or low folate levels. Mouse models allow us to control many of the genetic and environmental variables inherent in human studies, allowing us to dissect genes, pathways, and nutrients important for disease pathogenesis. Previous mouse studies showed that mutations in other pathways can significantly modulate functions of homocysteine and folate metabolism and modify disease phenotypes suggesting that these pathway interactions and their regulations are crucial to understanding the role of homocysteine and folate metabolism in complex diseases. To study these pathway interactions and their regulation, I used genetic, evolutionary, and genomic approaches. I first used a unique mouse strain PL/J to dissect the genetic control of key enzyme methylenetetrahydrofolate reductase (MTHFR) and its potential role in disease phenotypes. I found that seizure and kinky tail phenotype in these mice were 6 polygenic and showed strong environmental contributions. Next, I used evolutionary approaches to address whether biochemical interactions in metabolic pathways buffer deleterious mutations. I found that redundant metabolic paths do not provide genetic buffering as inferred from estimates of variation in gene evolution rates. However, higher level interactions explained some of the evolutionary rate variability. Lastly, I used genomic approaches to identify pathways that modulate homeostatic responses to dietary folate perturbations in two genetically distinct inbred strains. I found striking strain differences in homeostatic responses on folate retention and global gene expression profiles. I also found that cholesterol and choline metabolisms are involved in the folate perturbation response, which may play a more general role in complex disease mechanisms. Overall, these analyses revealed pathway interactions that are important for functionality of homocysteine and folate metabolism and highlighted some future strategies for dissecting the role of these pathways in complex diseases. 7 CHAPTER 1 Introduction and Objectives 8 Homocysteine, Folate, and Human Disease Risks Introduction Abnormalities in homocysteine and folate metabolism have been associated with a striking variety of complex human diseases. An elevated level of serum homocysteine is associated with increased risk for cardiovascular disease and Alzheimer’s disease. Low serum folate level or low dietary folate intake has also been associated with increased risk for mothers having children with neural tube defects and for colon and breast cancer. Genetic mutations in these metabolic pathways also elevate risks for these complex diseases (see Genetic Mutations in Homocysteine and Folate Metabolism). Serum homocysteine level in this thesis refers to the total serum homocysteine, which includes protein-bound homocysteine and soluble homocysteine. Protein-bound homocysteine accounts for nearly 80% and soluble homocysteine accounts for 20% of total homocysteine (Ueland 1995). The normal range of homocysteine is 5 to 15µM (Ueland et al. 1993, Graham et al. 1997). Elevated serum homocysteine beyond the normal range (>15uM) is traditionally
Load more

Recommended publications
  • Routine Administration of Vitamin K1 Prophylaxis to the Newborn
    Routine Administration of Vitamin K1 Prophylaxis to the Newborn Practice Resource for Health Care Providers July 2016 Practice Resource Guide: ROUTINE ADMINISTRATION OF VITAMIN K1 PROPHYLAXIS TO THE NEWBORN The information attached is the summary of the position statement and the recommendations from the recent CPS evidence-based guideline for routine intramuscular administration of Vitamin K1 prophylaxis to the newborn*: www.cps.ca/documents/position/administration-vitamin-K-newborns Summary Vitamin K deficiency bleeding or VKDB (formerly known as hemorrhagic disease of the newborn or HDNB) is significant bleeding which results from the newborn’s inability to sufficiently activate vitamin K-dependent coagulation factors because of a relative endogenous and exogenous deficiency of vitamin K.1 There are three types of VKDB: 1. Early onset VKDB, which appears within the first 24 hours of life, is associated with maternal medications that interfere with vitamin K metabolism. These include some anticonvulsants, cephalosporins, tuberculostatics and anticoagulants. 2. Classic VKDB appears within the first week of life, but is rarely seen after the administration of vitamin K. 3. Late VKDB appears within three to eight weeks of age and is associated with inadequate intake of vitamin K (exclusive breastfeeding without vitamin K prophylaxis) or malabsorption. The incidence of late VKDB has increased in countries that implemented oral vitamin K rather than intramuscular administration. There are three methods of Vitamin K1 administration: intramuscular, oral and intravenous. The Canadian Paediatric Society (2016)2 and the American Academy of Pediatrics (2009)3 recommend the intramuscular route of vitamin K administration. The intramuscular route of Vitamin K1 has been the preferred method in North America due to its efficacy and high compliance rate.
    [Show full text]
  • Dispensing of Vitamin Products by Retail Pharmacies in South Africa: Implications for Dietitians
    South African Journal of Clinical Nutrition 2016; 29(4):133–138 http://dx.doi.org/10.1080/16070658.2016.1219468 SAJCN ISSN 1607-0658 EISSN 2221-1268 Open Access article distributed under the terms of the © 2016 The Author(s) Creative Commons License [CC BY-NC 3.0] http://creativecommons.org/licenses/by-nc/3.0 RESEARCH Dispensing of vitamin products by retail pharmacies in South Africa: Implications for dietitians Ilse Trutera* and Liana Steenkampb a Department of Pharmacy, Drug Utilisation Research Unit (DURU), Nelson Mandela Metropolitan University, Port Elizabeth, South Africa b HIV & AIDS Research Unit, Nelson Mandela Metropolitan University, Port Elizabeth, South Africa *Corresponding author, email: [email protected] Objective: The objective of this study was to analyse the dispensing patterns of vitamins (Anatomical Therapeutic Chemical (ATC) group A11) over a one-year period in a group of community pharmacies in South Africa. Design and setting: A retrospective drug utilisation study was conducted on community pharmacy electronic dispensing records in South Africa recorded in 2013. Outcome measures: All products for ATC subgroup A11 were extracted and analysed. Results: A total of 164 233 vitamin products were dispensed to 84 805 patients (62.64% female patients). Males received on average 2.09 (SD = 2.63) vitamin products per year, compared to 1.84 (SD = 2.13) products for females. Ergocalciferol (A11CC01) was the most often dispensed (37.48% of all vitamin products), followed by plain Vitamin B-complex products (A11EA00) accounting for 32.77%. Ergocalciferol (vitamin D2) is only available on prescription (50 000 IU tablets or 50 000 IU/ml oily drops) in South Africa.
    [Show full text]
  • Vitamin K: Double Bonds Beyond Coagulation Insights Into Differences Between Vitamin K1 and K2 in Health and Disease
    International Journal of Molecular Sciences Review Vitamin K: Double Bonds beyond Coagulation Insights into Differences between Vitamin K1 and K2 in Health and Disease Maurice Halder 1,†, Ploingarm Petsophonsakul 2,†, Asim Cengiz Akbulut 2,†, Angelina Pavlic 2,† , Frode Bohan 3, Eric Anderson 3, Katarzyna Maresz 4, Rafael Kramann 1 and Leon Schurgers 1,2,* 1 Division of Nephrology, RWTH Aachen University, 52074 Aachen, Germany; [email protected] (M.H.); [email protected] (R.K.) 2 Department of Biochemistry, Cardiovascular Research Institute Maastricht, 6200MD Maastricht, The Netherlands; [email protected] (P.P.); [email protected] (A.C.A.); [email protected] (A.P.) 3 NattoPharma ASA, 0283 Oslo, Norway; [email protected] (F.B.); [email protected] (E.A.) 4 International Science & Health Foundation, 30-134 Krakow, Poland; [email protected] * Correspondence: [email protected]; Tel.: +31-43-3881680; Fax: +31-43-3884159 † These authors contributed equally to this work. Received: 24 January 2019; Accepted: 16 February 2019; Published: 19 February 2019 Abstract: Vitamin K is an essential bioactive compound required for optimal body function. Vitamin K can be present in various isoforms, distinguishable by two main structures, namely, phylloquinone (K1) and menaquinones (K2). The difference in structure between K1 and K2 is seen in different absorption rates, tissue distribution, and bioavailability. Although differing in structure, both act as cofactor for the enzyme gamma-glutamylcarboxylase, encompassing both hepatic and extrahepatic activity. Only carboxylated proteins are active and promote a health profile like hemostasis. Furthermore, vitamin K2 in the form of MK-7 has been shown to be a bioactive compound in regulating osteoporosis, atherosclerosis, cancer and inflammatory diseases without risk of negative side effects or overdosing.
    [Show full text]
  • An Abstract of the Thesis Of
    AN ABSTRACT OF THE THESIS OF Larry Stanford Merrifield for the M.S. in Food Science (Name) (Degree) (Major) Date thesis is presented June 26, 1964 Titie FACTORS AFFECTING THE ANTIMICROBIAL ACTIVITY OF VITAMIN K 5 Abstract approved (M^jor Tp&Sfesso/) Vitamin K, 4-amino-2-methyl- 1-naphthol hydrochloride, a 5 water soluble analog of vitamin K has been shown to possess an anti- microbial activity toward many bacteria, molds, and yeast. Much of the work reported in the literature is on its use as a food preserva- tive, and it was the purpose of this study to investigate some of the factors which might affect the antimicrobial activity of vitamin K in order to add insight into its more effective use as a food preserva- tive. Pure cultures of Escherichia coli, Bacillus subtilis, Proteus vulgaris, Staphlococcus aureus, and Pseudomonas fluorescens were utilized. The effect of the method of application of vitamin K on Escherichia coli; the effect of purity of vitamin K against Escherichia coli; the bactericidal concentrations required for Escherichia coli, Bacillus subtilis, Proteus vulgaris, Staphlococcus aureus, and Pseudomonas fluorescens; the effect of an absence of oxygen; the effect of contact time with Escherichia coli; the effect of initial count/ml of Escherichia coli; and the synergistic action in combination with propylene glycol were studied. The results demonstrated that air oxidation of vitamin K was 5 necessary to obtain maximum inhibitory activity against Escherichia coli. The use of white, crystalline vitamin K synthesized in the laboratory, as compared to partially oxidized commercial prepara- tions, gave better results against Escherichia coli.
    [Show full text]
  • Optimal Foods
    Optimal Foods 1. Almonds: high in monounsaturated and polyunsaturated fats, with 20% of calories coming from protein and dietary fiber. Nutrients include potassium, magnesium, calcium, iron, zinc, vitamin E and an antioxidant flavonoid called amygdlin also known as laetrile. 2. Barley: Like oat bran it is high in beta-glucan fiber which helps to lower cholesterol. Nutrients include copper, magnesium, phosphorous and niacin. 3. Berries : The darker the berry the higher in anti-oxidants. Nutritionally they are an excellent source of flavonoids, especially anthocyanidins, vitamin C and both soluble and insoluble fiber. 4. Brussels Sprouts : Similar to broccoli, and a member of the cabbage family, it contains cancer fighting glucosinolates. Nutritionally it is an excellent source of vitamin C and K, the B vitamins, beta-carotene, potassium and dietary fiber. 5. Carrots: It contains the highest source of proviatamin A carotenes as well as vitamin K, biotin, vitamin C, B6, potassium, thiamine and fiber. 6. Dark Chocolate: It is rich in the flavonoids, similar to those found in berries and apples, that are more easily absorbed than in other foods. It also provides an amino acid called arginine that helps blood vessels to dilate hence regulating blood flow and helping to lower blood pressure. Choose high-quality semisweet dark chocolate with the highest cocoa content that appeals to your taste buds. 7. Dark leafy greens : Kale, arugula, spinach, mustard greens, chard, collards, etc: low calorie, anti-oxidant dense food with carotenes, vitamin C, folic acid, manganese, copper, vitamin E, copper, vitamin B6, potassium, calcium, iron and dietary fiber. Kale is a particularly excellent bioavailable source of calcium while spinach is not.
    [Show full text]
  • The Potential Protective Role of Vitamin K in Diabetic Neuropathy
    VITAMINS The potential protective role of vitamin K in diabetic neuropathy DILIP MEHTA Viridis Biopharma 6/10 Jogani Industrial Complex ew cases of diabetes are symptomatic pain relief (3-5). V. N. Purav Marg, Chunabhatti increasing worldwide at a rapid Mumbai 400022, India The etiopathology of peripheral pace, with the total number of neuropathy is poorly understood and many [email protected] people with diabetes was projected factors, including dietary deficiencies, may www.viridisbiopharma.com Nto rise from 171 million in 2000 to 366 million contribute to the clinical manifestation of the in 2030 – an increase of nearly 200 million in condition. Deficiency of vitamin B12 (also only three decades. There are more cases of known as cobalamin), which results in a lack diabetes in women and urban populations, of a related compound, methylcobalamin, is with diabetes in developing countries projected manifested by megaloblastic anemia, and to double in the coming years (1). has been associated with significant Based on reports from the Centers for neurological pathology, especially peripheral Disease Control and Prevention, type 2 neuropathy (6-8). Vitamin B12 is also diabetes dult onset diabetes affects associated with the onset of diabetic approximately 9.3% of the general neuropathy. In patients with diabetic population in the United States in contrast to neuropathy, vitamin B12 deficiency may be 25.9% among those 65 years or older (2). aggravated by the use of antidiabetic agents Diabetes mellitus accounts for 90% of the such as metformin (9-11). Even short-term cases of diabetes patients (3,4). treatment with metformin causes a decrease The prevalence of type 2 diabetes in serum cobalamin, folic acid and an increases with age, higher then 25 body increase in homocysteine, which leads to mass index and the presence of the disease peripheral neuropathy in patients with in family history.
    [Show full text]
  • Dietary Reference Intakes (Dris): Recommended Dietary Allowances and Adequate Intakes, Vitamins Food and Nutrition Board, Institute of Medicine, National Academies
    Dietary Reference Intakes (DRIs): Recommended Dietary Allowances and Adequate Intakes, Vitamins Food and Nutrition Board, Institute of Medicine, National Academies Life Stage Vitamin A Vitamin C Vitamin D Vitamin E Vitamin K Thiamin Riboflavin Niacin Vitamin B6 Folate Vitamin B12 Pantothenic Biotin Choline Group (µg/d)a (mg/d) (µg/d)b,c (mg/d) d (µg/d) (mg/d) (mg/d) (mg/d)e (mg/d) (µg/d)f (µg/d) Acid (mg/d) (µg/d) (mg/d)g Infants 0 to 6 mo 400* 40* 10 4* 2.0* 0.2* 0.3* 2* 0.1* 65* 0.4* 1.7* 5* 125* 6 to 12 mo 500* 50* 10 5* 2.5* 0.3* 0.4* 4* 0.3* 80* 0.5* 1.8* 6* 150* Children 1–3 y 300 15 15 6 30* 0.5 0.5 6 0.5 150 0.9 2* 8* 200* 4–8 y 400 25 15 7 55* 0.6 0.6 8 0.6 200 1.2 3* 12* 250* Males 9–13 y 600 45 15 11 60* 0.9 0.9 12 1.0 300 1.8 4* 20* 375* 14–18 y 900 75 15 15 75* 1.2 1.3 16 1.3 400 2.4 5* 25* 550* 19–30 y 900 90 15 15 120* 1.2 1.3 16 1.3 400 2.4 5* 30* 550* 31–50 y 900 90 15 15 120* 1.2 1.3 16 1.3 400 2.4 5* 30* 550* 51–70 y 900 90 15 15 120* 1.2 1.3 16 1.7 400 2.4h 5* 30* 550* > 70 y 900 90 20 15 120* 1.2 1.3 16 1.7 400 2.4h 5* 30* 550* Females 9–13 y 600 45 15 11 60* 0.9 0.9 12 1.0 300 1.8 4* 20* 375* 14–18 y 700 65 15 15 75* 1.0 1.0 14 1.2 400i 2.4 5* 25* 400* 19–30 y 700 75 15 15 90* 1.1 1.1 14 1.3 400i 2.4 5* 30* 425* 31–50 y 700 75 15 15 90* 1.1 1.1 14 1.3 400i 2.4 5* 30* 425* 51–70 y 700 75 15 15 90* 1.1 1.1 14 1.5 400 2.4h 5* 30* 425* > 70 y 700 75 20 15 90* 1.1 1.1 14 1.5 400 2.4h 5* 30* 425* Pregnancy 14–18 y 750 80 15 15 75* 1.4 1.4 18 1.9 600j 2.6 6* 30* 450* 19–30 y 770 85 15 15 90* 1.4 1.4 18 1.9 600j 2.6 6* 30* 450* 31–50 y 770 85 15 15 90* 1.4 1.4 18 1.9 600j 2.6 6* 30* 450* Lactation 14–18 y 1,200 115 15 19 75* 1.4 1.6 17 2.0 500 2.8 7* 35* 550* 19–30 y 1,300 120 15 19 90* 1.4 1.6 17 2.0 500 2.8 7* 35* 550* 31–50 y 1,300 120 15 19 90* 1.4 1.6 17 2.0 500 2.8 7* 35* 550* NOTE: This table (taken from the DRI reports, see www.nap.edu) presents Recommended Dietary Allowances (RDAs) in bold type and Adequate Intakes (AIs) in ordinary type followed by an asterisk (*).
    [Show full text]
  • 1A Multiple Sclerosis Treatment
    The Pharmacogenomics Journal (2012) 12, 134–146 & 2012 Macmillan Publishers Limited. All rights reserved 1470-269X/12 www.nature.com/tpj ORIGINAL ARTICLE Network analysis of transcriptional regulation in response to intramuscular interferon-b-1a multiple sclerosis treatment M Hecker1,2, RH Goertsches2,3, Interferon-b (IFN-b) is one of the major drugs for multiple sclerosis (MS) 3 2 treatment. The purpose of this study was to characterize the transcriptional C Fatum , D Koczan , effects induced by intramuscular IFN-b-1a therapy in patients with relapsing– 2 1 H-J Thiesen , R Guthke remitting form of MS. By using Affymetrix DNA microarrays, we obtained and UK Zettl3 genome-wide expression profiles of peripheral blood mononuclear cells of 24 MS patients within the first 4 weeks of IFN-b administration. We identified 1Leibniz Institute for Natural Product Research 121 genes that were significantly up- or downregulated compared with and Infection Biology—Hans-Knoell-Institute, baseline, with stronger changed expression at 1 week after start of therapy. Jena, Germany; 2University of Rostock, Institute of Immunology, Rostock, Germany and Eleven transcription factor-binding sites (TFBS) are overrepresented in the 3University of Rostock, Department of Neurology, regulatory regions of these genes, including those of IFN regulatory factors Rostock, Germany and NF-kB. We then applied TFBS-integrating least angle regression, a novel integrative algorithm for deriving gene regulatory networks from gene Correspondence: M Hecker, Leibniz Institute for Natural Product expression data and TFBS information, to reconstruct the underlying network Research and Infection Biology—Hans-Knoell- of molecular interactions. An NF-kB-centered sub-network of genes was Institute, Beutenbergstr.
    [Show full text]
  • X-Linked Transposition of the Great Arteries and Incomplete Penetrance Among Males with a Nonsense Mutation in ZIC3
    European Journal of Human Genetics (2000) 8, 704–708 y © 2000 Macmillan Publishers Ltd All rights reserved 1018–4813/00 $15.00 www.nature.com/ejhg ARTICLE X-linked transposition of the great arteries and incomplete penetrance among males with a nonsense mutation in ZIC3 Andr´e M´egarban´e1, Nabiha Salem1, Edouard Stephan2, Ramzi Ashoush3, Didier Lenoir4, Val´erie Delague1, Roland Kassab4, Jacques Loiselet1 and Patrice Bouvagnet4,5 1Unit´e de G´en´etique M´edicale, Facult´e de M´edecine, Universit´e Saint-Joseph, Beirut; 2Facult´e de M´edecine, Universit´e Saint-Joseph, Beirut; 3Service de Chirurgie Cardio-Vasculaire et de Cardiologie, Hˆotel-Dieu de France, Beirut, Lebanon; 4Laboratoire de G´en´etique Mol´eculaire Humaine, Facult´e de M´edecine et Pharmacie, Universit´e Claude Bernard, Lyon; 5Service de Cardiologie P´ediatrique, Hˆopital Louis Pradel, Bron, France We report on a Lebanese family in which two maternal cousins suffered and died very early in life from cardiac malformations. Both presented with a transposition of the great arteries associated with one or several other cardiac defects. Various minor midline defects were also observed, but there were no situs abnormalities other than a persistent left superior vena cava in one. A maternal uncle of these two babies was born cyanotic and died on the third post-natal day. Analysis of the ZIC3 gene, revealed the presence of a mutation in the second exon leading to a truncation of the protein. Surprisingly, another maternal uncle of the two affected cousins also had the mutation but was not clinically affected.
    [Show full text]
  • Somatic Mosaicism Underlies X-Linked Acrogigantism Syndrome in Sporadic Male Subjects
    234 A F Daly et al. Somatic mosaicism underlies 23:4 221–233 Research X-linked acrogigantism Somatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjects Adrian F Daly1,*, Bo Yuan2,*, Frederic Fina3,4,*, Jean-Hubert Caberg5, Giampaolo Trivellin6, Liliya Rostomyan1, Wouter W de Herder7, Luciana A Naves8, Daniel Metzger9, Thomas Cuny10, Wolfgang Rabl11, Nalini Shah12, Marie-Lise Jaffrain-Rea13, Maria Chiara Zatelli14, Fabio R Faucz6, Emilie Castermans5, Isabelle Nanni-Metellus3, Maya Lodish6, Ammar Muhammad7, Leonor Palmeira1, Iulia Potorac1,5, Giovanna Mantovani15, Sebastian J Neggers7, Marc Klein10, Anne Barlier16,17, Pengfei Liu2, L’Houcine Ouafik4, Vincent Bours5, James R Lupski2,18,19, Constantine A Stratakis6,† and Albert Beckers1,† 1Department of Endocrinology, Centre Hospitalier Universitaire de Liege, University of Liege, Liege, Belgium 2Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA 3Assistance Publique Hôpitaux de Marseille (AP-HM), Hôpital Nord, Service de Transfert d’Oncologie Biologique, Marseille, France 4Laboratoire de Biologie Médicale, and Aix-Marseille Université, Inserm, CRO2 UMR_S 911, Marseille, France 5Department of Human Genetics, Centre Hospitalier Universitaire de Liege, University of Liege, Liege, Belgium 6Section on Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), Bethesda, Maryland, USA 7Section of Endocrinology, Department of Medicine,
    [Show full text]
  • Comparative Transcriptomics Reveals Similarities and Differences
    Seifert et al. BMC Cancer (2015) 15:952 DOI 10.1186/s12885-015-1939-9 RESEARCH ARTICLE Open Access Comparative transcriptomics reveals similarities and differences between astrocytoma grades Michael Seifert1,2,5*, Martin Garbe1, Betty Friedrich1,3, Michel Mittelbronn4 and Barbara Klink5,6,7 Abstract Background: Astrocytomas are the most common primary brain tumors distinguished into four histological grades. Molecular analyses of individual astrocytoma grades have revealed detailed insights into genetic, transcriptomic and epigenetic alterations. This provides an excellent basis to identify similarities and differences between astrocytoma grades. Methods: We utilized public omics data of all four astrocytoma grades focusing on pilocytic astrocytomas (PA I), diffuse astrocytomas (AS II), anaplastic astrocytomas (AS III) and glioblastomas (GBM IV) to identify similarities and differences using well-established bioinformatics and systems biology approaches. We further validated the expression and localization of Ang2 involved in angiogenesis using immunohistochemistry. Results: Our analyses show similarities and differences between astrocytoma grades at the level of individual genes, signaling pathways and regulatory networks. We identified many differentially expressed genes that were either exclusively observed in a specific astrocytoma grade or commonly affected in specific subsets of astrocytoma grades in comparison to normal brain. Further, the number of differentially expressed genes generally increased with the astrocytoma grade with one major exception. The cytokine receptor pathway showed nearly the same number of differentially expressed genes in PA I and GBM IV and was further characterized by a significant overlap of commonly altered genes and an exclusive enrichment of overexpressed cancer genes in GBM IV. Additional analyses revealed a strong exclusive overexpression of CX3CL1 (fractalkine) and its receptor CX3CR1 in PA I possibly contributing to the absence of invasive growth.
    [Show full text]
  • Heterotaxy and Cardiac Defect in a Girl with Chromosome Translocation T(X;1)(Q26;P13.1) and Involvement of ZIC3
    European Journal of Human Genetics (2006) 14, 1317–1320 & 2006 Nature Publishing Group All rights reserved 1018-4813/06 $30.00 www.nature.com/ejhg SHORT REPORT Heterotaxy and cardiac defect in a girl with chromosome translocation t(X;1)(q26;p13.1) and involvement of ZIC3 Andreas Tzschach*,1, Maria Hoeltzenbein1, Kirsten Hoffmann1, Corinna Menzel1, Alexander Beyer2, Volker Ocker3, Goetz Wurster4, Martine Raynaud5, Hans-Hilger Ropers1, Vera Kalscheuer1 and Helmut Heilbronner6 1Department Ropers, Max Planck Institute for Molecular Genetics, Berlin, Germany; 2Surgery of Paediatric Cardiology, Stuttgart, Germany; 3Department of Paediatrics, Olgahospital, Stuttgart, Germany; 4Surgery of Gynaecology,Stuttgart, Germany; 5Service de Ge´ne´tique et INSERM U316, Hoˆpital Bretonneau, Tours Cedex, France; 6Institute of Clinical Genetics, Olgahospital, Stuttgart, Germany We report on a 2-year-old girl with situs ambiguus comprising right-sided stomach and spleen, left-sided liver and complex cardiac defect. Psychomotor development of this patient was normal, and no other major abnormalities were present. Chromosome analysis revealed a de novo balanced chromosome translocation t(X;1)(q26;p13.1). Molecular cytogenetic investigations identified a breakpoint spanning BAC clone on the X-chromosome containing the ZIC3 gene. Mutations in ZIC3 are associated with situs ambiguus and cardiac defects predominantly in males. This is the first report of a live born girl with an X-autosome translocation involving the ZIC3 region. European Journal of Human Genetics (2006) 14, 1317–1320. doi:10.1038/sj.ejhg.5201707; published online 23 August 2006 Keywords: ZIC3; situs ambiguus; heterotaxy; congenital cardiac defect; balanced chromosome translocation Introduction encodes a zinc-finger transcription factor (MIM 306955).2–6 Heterotaxy is a class of congenital malformations resulting ZIC3-associated heterotaxy is an X-linked recessive disorder from failed establishment of left–right asymmetry of the of variable clinical expression that predominantly affects thoracic and visceral organs.
    [Show full text]